Cargando…

Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition

Detalles Bibliográficos
Autores principales: Yamazaki, Shinji, Evers, Raymond, De Zwart, Loeckie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574732/
https://www.ncbi.nlm.nih.gov/pubmed/36048879
http://dx.doi.org/10.1002/psp4.12860
_version_ 1784811166366695424
author Yamazaki, Shinji
Evers, Raymond
De Zwart, Loeckie
author_facet Yamazaki, Shinji
Evers, Raymond
De Zwart, Loeckie
author_sort Yamazaki, Shinji
collection PubMed
description
format Online
Article
Text
id pubmed-9574732
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95747322022-10-17 Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition Yamazaki, Shinji Evers, Raymond De Zwart, Loeckie CPT Pharmacometrics Syst Pharmacol Corrigendum John Wiley and Sons Inc. 2022-09-01 2022-10 /pmc/articles/PMC9574732/ /pubmed/36048879 http://dx.doi.org/10.1002/psp4.12860 Text en © 2022 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of the American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Corrigendum
Yamazaki, Shinji
Evers, Raymond
De Zwart, Loeckie
Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition
title Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition
title_full Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition
title_fullStr Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition
title_full_unstemmed Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition
title_short Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition
title_sort corrigendum to: physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal p‐glycoprotein inhibition
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574732/
https://www.ncbi.nlm.nih.gov/pubmed/36048879
http://dx.doi.org/10.1002/psp4.12860
work_keys_str_mv AT yamazakishinji corrigendumtophysiologicallybasedpharmacokineticmodelingtoevaluateinvitrotoinvivoextrapolationforintestinalpglycoproteininhibition
AT eversraymond corrigendumtophysiologicallybasedpharmacokineticmodelingtoevaluateinvitrotoinvivoextrapolationforintestinalpglycoproteininhibition
AT dezwartloeckie corrigendumtophysiologicallybasedpharmacokineticmodelingtoevaluateinvitrotoinvivoextrapolationforintestinalpglycoproteininhibition